Daxor Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 303.71K and sold 0 DXR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 303.71K shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 08, 2026
Buy
Daxor Common Stock
P-Purchase
Feldschuh Michael Richard
Chief Executive Officer
CEO / President 1 000
Value: $9K
Mar 31, 2026
Buy
Daxor Common Stock
P-Purchase
Michel Robert J
Chief Financial Officer
C-Suite Officer 1 000
Value: $10K
Mar 20, 2026
Buy
Daxor Common Stock
P-Purchase
Jefferies John
Chief Medical Officer
Officer 2 285
Value: $25.0K
Mar 20, 2026
Buy
Daxor Common Stock
P-Purchase
Jefferies John
Chief Medical Officer
Officer 3 656
Value: $40.0K
Dec 09, 2025
Buy
Daxor Common Stock
P-Purchase
Feldschuh Jonathan Adam
Chief Scientific Officer
Officer 18 000
Value: $225.0K
Dec 09, 2025
Buy
Daxor Common Stock
P-Purchase
Michel Robert J
Chief Financial Officer
C-Suite Officer 3 000
Value: $37.5K
Nov 12, 2025
Buy
Daxor Common Stock
P-Purchase
Jefferies John
Chief Medical Officer
Officer 2 344
Value: $31.1K
Sep 30, 2025
Buy
Daxor Common Stock
Jefferies John
Chief Medical Officer
Officer 0
Value: $0
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 885
Value: $10.0K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 14 660
Value: $140.0K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 539
Value: $5K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 236
Value: $3K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 309
Value: $4K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 448
Value: $6K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 284
Value: $4K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 406
Value: $5K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 327
Value: $4K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 469
Value: $5K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 380
Value: $4K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 199
Value: $2K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 216
Value: $2K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 116
Value: $1K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 353
Value: $4K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 221
Value: $2K
Sep 30, 2025
Buy
Stock Options (right to buy)
Jefferies John
Chief Medical Officer
Officer 275
Value: $2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT DAXOR CORP
Daxor
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE